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The recent furore about the disclosure of the health conditions 
of Shabir Shaik and the Minister of Health and a press 
statement by the Health Professions Council of South Africa 
(HPSCA)1 have raised the question of when it is justified for 
medical practitioners to disclose the medical condition of public 
figures to the public or other persons. 
Everyone has a constitutional2 and common law right to 
privacy3 concerning their health status, but the right is not 
unlimited and may be infringed where the person concerned 
consents; where there is a statutory duty to make disclosure 
(e.g. child abuse);4 where it is reasonable for the media to make 
the disclosure;5 where the disclosure is true and in the public 
interest; or where the disclosure is privileged.6  The defences 
to an action for invasion of privacy are similar to those for 
defamation.7 The defences of truth for the public interest and 
privilege are particularly relevant to disclosures concerning the 
health status of public figures.
Who is a public figure? 
Public figures are people who have by their personality, status 
or conduct exposed themselves to such a degree of publicity as 
to justify public disclosures of certain aspects of their private 
lives.8  Such persons include politicians, actors, entertainers, 
sportsmen and sportswomen, war heroes, and others who are 
regarded as having a limited right to privacy. This is because 
they have sought or consented to publicity, their personalities 
and affairs have already become public, and the media have a 
duty to inform the public about them.9
Disclosures about public figures should be relevant to how 
they conduct themselves in public or where their private affairs 
are in the public interest. For instance, it would be in the public 
interest to know that a public official, a judge or a person in 
charge of a professional body has a drug or alcohol problem 
where such problem interferes with their ability to carry out 
their public or professional duties properly. Likewise, it would 
in the public interest to know about the disease that afflicts a 
senior health official who is so ill that he cannot carry out his 
public duties because he is using an unorthodox treatment 
regimen that he is publicly promoting instead of conventional 
medicine. Similarly, it would be in the public interest to know 
that an ex-Presidential spokesperson had died of an AIDS-
related illness some time after he had publicly rejected the 
opinion of thousands of reputable scientists who had stated that 
there was a direct link between HIV and AIDS.
Public figures are more likely than ordinary people to have 
disclosures about aspects of their private lives disclosed 
(including their health), because they seek or are exposed to 
publicity and their private acts or omissions may impinge on 
their public life.
Defence of truth for the public benefit
A disclosure concerning a person’s health status may not be 
unlawful if the statement is true and for the public benefit.6 
Truth 
Truth does not mean that the disclosure has to be true in all 
respects – provided it is substantially true in the sense that the 
material facts are true.10 For instance, if a statement is made that 
a person died of AIDS instead of an AIDS-related illness the 
statement could be regarded as substantially true because the 
phrase ‘died of AIDS’ is commonly used by lay people. Truth 
by itself will not be a defence to a public disclosure concerning 
a person’s health status – it must be linked to public benefit or 
interest for the defence to succeed.10
Public benefit and public interest
Public benefit means the same as public interest and refers 
to ‘material in which the public has an interest’ – not ‘what 
the public finds interesting’.5 Public interest includes aspects 
of the private lives of public figures that are relevant to their 
public lives. For example, if an HIV-positive parliamentarian 
is opposed to the idea of the government rolling out an 
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drugs it will be in the public interest to disclose the fact that she 
is on a treatment regimen that she is seeking to deny others.
Public interest also includes matters that are in the public 
domain such as politics, governance, administration of justice, 
administration of public or professional bodies, sport and 
the arts. It also includes people catapulted into the public eye 
– even against their will – for example people charged with 
crimes or the victims of natural disasters, crimes or public 
scandals.8 In such cases the disclosures must be relevant to the 
person’s predicament and the public interest. For example, if a 
high-profile politician is convicted of a crime and manages to 
avoid being incarcerated in prison because of illness it would 
be in the public interest to disclose his health status if his illness 
does not justify keeping him out of prison. 
It can be argued, however, that if it is shown that the 
disclosure about a person’s health status was motivated by 
malice or spite the defence of truth for the public benefit will be 
defeated because it would be an abuse of rights, as is the case 
with the defence of qualified privilege.11
Defence of privilege
The defence of privilege takes two forms – absolute and 
qualified privilege.6
Absolute privilege
Disclosures concerning a person’s health made during national 
and provincial parliamentary proceedings are subject to an 
absolute privilege and may not give rise to legal proceedings 
– even if made out of spite or malice.12 For example, if a national 
or provincial parliamentarian discloses the health status of 
the President, a Cabinet Minister, another parliamentarian, a 
Member of the Executive Council, or a member of the public 
during parliamentary proceedings, such disclosure will be 
privileged and not subject to legal action – no matter what 
motivates the disclosure.
Qualified privilege 
A relevant disclosure about a person’s health status made in the 
discharge of a legal, moral or social duty to a person who has 
a legitimate interest or duty in receiving the disclosure will be 
regarded as subject to a qualified privilege.11 The same applies 
to relevant disclosures published during judicial or quasi-
judicial proceedings or in reports of the proceedings of courts, 
parliament or public bodies.13
The test is whether an ordinary, reasonable person having 
regard to the relationship of the parties and the surrounding 
circumstances would have made the disclosure.11 For example, 
a third-party private hospital doctor may tell a prison official 
that a sentenced prisoner who is in a private ward in order to 
avoid imprisonment is not so ill that he cannot return to prison 
to carry out his prison sentence.  It could be argued that a 
similar disclosure could be made by the doctor to a newspaper 
reporter on the basis that the doctor would have a moral or 
social duty to expose medical fraud by a prisoner and the mass 
media would have a duty to inform the public about such 
conduct.5
The privilege is regarded as qualified because it may be 
defeated by proof of malice or spite on the part of the person 
making the disclosure.11
Ethical rules of the HPCSA
Rule 12 of the ethical rules of the HPCSA provide, inter alia, 
that:
 ‘A practitioner shall only divulge verbally or in writing any 
information regarding a patient which he or she ought to 
divulge in terms of a statutory provision or at the instruction 
of a court of law or where justified in the public interest’.14
Rule 12 recognises that when it is in the public interest 
there may be ethical grounds for making a disclosure about 
the health of a patient.  The test for when a disclosure about a 
person’s health status will be in the public interest will be the 
same as that required by the law. Thus it would not be unethical 
to disclose that a dishonest HIV-positive parliamentarian was 
receiving antiretroviral drugs while seeking to deny the right to 
others, or that a prominent prisoner was fraudulently avoiding 
imprisonment on flimsy medical grounds.
Statutory provisions
The National Health Act provides that all information 
concerning a user or patient, ‘including information relating 
to his or her health status, treatment or stay in a health 
establishment, is confidential’.15 Furthermore, no person may 
disclose any information about a patient unless (i) the patient 
consents to the disclosure in writing; (ii) a court order or any 
law requires that disclosure; or (iii) non-disclosure of the 
information represents a serious threat to public health.16
The National Health Act therefore allows disclosures 
about a person’s health status, treatment or stay in a health 
establishment, inter alia, if a law requires such disclosure, or 
non-disclosure will pose a serious threat to public health. 
The law does not require disclosures concerning a person’s 
health in situations where it is true and for the public benefit 
or on a privileged occasion. However, the law will protect a 
person who makes a disclosure under such circumstances – for 
instance, disclosures about the health status of the hypocritical 
HIV-positive parliamentarian on antiretroviral drugs who 
opposes their being given to others. It could also be argued that 
such a person poses a serious threat to public health by seeking 
to deny HIV-positive people access to life-saving drugs.
The National Health Act therefore recognises that the 
right to privacy is not unlimited and that disclosures about a 
person’s health status may be made under certain restrictive 
circumstances – this is particularly so where the public interest 
is involved.
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Public figures, like ordinary people, have a right to privacy, 
but their rights are more limited because they seek publicity 
or conduct their affairs in public. If the health status of public 
figures is relevant to their public activities it may be disclosed 
by doctors in situations where such disclosure is true for the 
public benefit or is made on a privileged occasion.
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Before we rush to administer the ‘silver bullet’ of circumcision 
in the fight against HIV/AIDS, it is important to take a long 
cool look at the practice, and the historical and contemporary 
rationales for its use.
Circumcision practices
In his book Circumcision, A History of the World’s Most 
Controversial Surgery,1 medical historian David Gollaher 
makes the intriguing suggestion that ‘as the history of female 
circumcision suggests, if male circumcision were confined 
to developing nations, it would by now have emerged as an 
international cause célèbre, stirring passionate opposition from 
feminists, physicians, politicians, and the global human rights 
community’.  
There are clearly ethical issues involved in practising genital 
surgery on non-consenting infants and children in a modern 
human rights context; however, because male circumcision has 
long been familiar in the West, it continues to be justified and 
escape scrutiny. 
Rationalisations for circumcision
Over the centuries there have been various justifications for 
male circumcision. The practice has served in part to identify 
those outside the religious/cultural group. The unsubstantiated 
rationale is that the circumcised penis is ‘cleaner’ than the 
uncircumcised one. This argument is often encountered among 
Jews, Muslims and Americans, all of whom circumcise the 
majority of males in infancy or childhood, but the notion 
is absent for example in Scandinavian countries where 
circumcision is rare.
More serious and superficially more convincing justifications 
for this surgery, such as ‘health benefits’ or ‘medical’ reasons 
have abounded since the mid-19th century. The first medical 
justification was that circumcision prevents masturbation,2 
which Victorians believed led to a range of maladies including 
insanity, idiocy, epilepsy, tuberculosis and paralysis.3 This 
claim proved false. At the turn of the 20th century it was 
claimed that circumcision prevents sexually transmitted 
diseases (STDs), with studies4 finding differences in the rates 
of syphilis and other STDs among Jews and non-Jews. These 
early studies did not adjust for confounding factors, and later 
well-conducted studies failed to find a protective effect.5  In 
the 1930s circumcision was said to prevent penile cancer.6 
However, because penile cancer is so rare (every year there is 1 
case per 100 000 men in the USA and 0.3/100 000 in Japan7), the 
American Cancer Society estimates that the number of fatalities 
from circumcision would exceed the number of fatalities 
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between circumcision and low rates of cervical cancer in 
women; however, this finding was not substantiated in further 
studies.9 In the 1980s the new scare was urinary tract infection 
in the first year of life.10 It was argued that the likelihood of this 
would be decreased if the infant was circumcised. However, 
even accepting this to be true, the absolute risk reduction 
is very small (under 1%).11 Interestingly, girls are far more 
susceptible to urinary tract infections than both circumcised 
and intact boys. In girls (and in the small number of excess 
cases in intact males), antibiotic treatment is effective. It is also 
worth noting that none of the abovementioned conditions are 
eliminated by circumcision. The most that can possibly be said 





As medical justifications for routine infant circumcision have 
been steadily overturned, medical organisations in Anglophone 
countries (the only countries with a history of medicalised 
non-therapeutic or preventive circumcision) formulated policies 
that withheld endorsement of routine circumcision of infants, 
and accordingly the rates dropped considerably in all but 
the USA. The UK stopped coverage of circumcision via the 
National Health Service in 1949 because of lack of evidence 
of benefit,12 and the American Academy of Paediatrics (AAP) 
stopped endorsement of routine circumcision in 1971, citing 
no valid indications.13 An AAP statement in 1989 elaborated 
on risks and benefits,14 and in its most recent policy statement 
in 1999 the AAP reaffirmed that routine circumcision was not 
recommended.15
Until recently infant male circumcision has been on the 
decline, as parents in developed countries began increasingly 
to perceive that genital surgery on non-consenting subjects was 
not only unnecessary, but also inhumane and out of step with 
an evolved human rights culture. Circumcision appeared to 
be going the way of other outdated practices such as corporal 
and capital punishment and less humane slaughtering and 
animal sacrifice practices. In the USA, UK and Israel, small but 
increasing numbers of Jews oppose the practice as antiquated, 
and refuse to have it done to their infants, despite its religious 
and cultural significance.16-19
The evidence for HIV prevention
Before the implementation of properly designed randomised 
control trials (RCTs), the authoritative Cochrane Review of 
recent studies on the subject found ‘insufficient evidence to 
support an interventional effect of male circumcision on HIV 
acquisition in heterosexual men’.20 Results of observational 
studies were conflicting and no strong association was 
observed.  However, results of recent RCTs21-23 examining the 
effect of adult male circumcision on the risk of HIV infection 
have once again led to renewed medical justifications and calls 
for circumcision.24-27 There have been calls for mass circumcision 
campaigns, even though these might be impractical in many 
circumstances. Although some commentators have been 
careful to emphasise that circumcision has only been shown to 
reduce the risk, many lay people are beginning to believe that 
circumcision can prevent (in the sense of eliminate) the risk.
Recent RCTs have shown that over a maximum period of 
24 months of observation post circumcision, a man’s risk of 
contracting HIV is reduced by between 60% (see South African 
study21) and 53% and 51% (see Kenyan22 and Ugandan23 studies) 
respectively.  Garenne28 has pointed out that a 60% reduction in 
the risk of infection is similar to the effectiveness of the rhythm 
method of contraception, which reduces fecundity by around 
50% without protecting women against pregnancy.
A circumcised man cannot hope for full immunity to HIV; the 
best he can hope for is perhaps a longer period of time and/
or a greater number of sexual encounters before he becomes 
infected as a consequence of his reduced risk. The problem is 
that if people are led to believe that circumcision is actually 
‘protective’ in the sense of conferring full immunity, this could 
be seriously counterproductive, resulting in behavioural 
disinhibition in circumcised men and their abandonment of 
other preventive methods.  
At the population level there is no notable correlation 
between circumcision and HIV status. In Europe, where few 
men are circumcised, HIV prevalence is the lowest in the world. 
In the USA, where most men are circumcised, HIV prevalence 
is highest in the developed world. In Ethiopia, despite the 
universal practice of circumcision, the number of HIV cases 
increased from 0% in 1984 to 7.4% in 1997.29 In the Eastern 
Cape, where most men are circumcised, the prevalence rate is 
not meaningfully lower than in KwaZulu-Natal (KZN), where 
most men are not circumcised. The pandemic in the former 
province appears merely to be lagging behind that in KZN.28
While these findings are not incompatible with evidence 
from trials showing that circumcision reduces the risk of 
HIV transmission, they demonstrate that there are far more 
important factors affecting HIV spread than the absence of 
circumcision.  Actuarial modelling showing the impact that 
mass circumcision might have in South Africa provides an 
estimate of a modest 9% reduction in the incidence of HIV cases 
over the next 10 years30 (an average risk reduction of less than 
1% a year).
Unbalanced circumcision advocacy
The current zeal and naïve enthusiasm for promoting 
circumcision as an AIDS prevention tool show lack of regard 
for the limited degree of benefit likely. Potential harms include 
disinhibition and surgical complications like infection and 
worse at the individual level, and increased costs and strain on 
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thinly stretched health services and the opportunity cost of de-
emphasising other crucial health services at the societal level. 
Recent research has shown that HIV infection is about three 
times more likely as a result of the circumcision procedure itself 
in three African settings (Kenya, Lesotho and Tanzania).31 One 
should also not lose sight of the ethical issues of circumcising 
non-consenting infants.
Cultural double standards
It is also useful to ask ourselves how consistent attitudes are 
in relation to preventive surgery. Hypothetically, imagine that 
female circumcision had also been shown to have a similar 
‘protective’ effect. Would we be any more likely to promote 
it? Would women be lining up for it, and would young 
parents, eager to do the best for their children, request it for 
their daughters? If female circumcision was medicalised in a 
similar way to male circumcision, it could be made safer and 
less damaging. Nevertheless, that sort of argument does not 
convince. 
Although it is not deemed ethically possible to study female 
circumcision by means of a RCT, a large Tanzanian study, which 
controlled for confounding variables, found that this practice 
reduced HIV transmission.32 Biologically the explanation for 
this is probably the same as for male circumcision.  
The downplaying of these facts in the media is a powerful 
reflection of Western cultural attitudes. We have already 
decided that female circumcision is an appalling human rights 
violation and so do not even flirt with the idea of using it as an 
HIV prevention tool.  Similar arguments apply to mastectomy 
in teenage girls, even though this would be effective to prevent 
breast cancer in later life. The difference with male circumcision 
is that it is still tolerated in Western and other parts of the 
world, rendering it politically acceptable. This has tended to 
lower ethical barriers to recommending male circumcision as an 
HIV/AIDS preventive measure.
Caution and more research are needed
More research is needed into integrated HIV/AIDS manage-
ment that examines the long-term preventive effects of circum-
cision. Research should focus on the duration of sexual activity 
in men (as with the rhythm method of contraception over the 
reproductive years of women), the impact on female risk of 
acquiring HIV, and on the issue of disinhibition in circumcised 
men. The impact on women is a key issue, and recent research 
in Uganda shows that female partners of circumcised men 
appear twice as likely to contract HIV;33 while South African 
research shows that of the principal group at risk for HIV infec-
tion – 15 - 24-year-olds – a massive 90% of those newly infected 
were women.34 In summary, the evidence for preventive benefit 
of male circumcision is rather modest and does not warrant 
heroic policies or practices.  
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